Annual CFI
$4.93 M
+$9.85 M+200.19%
December 31, 2023
Summary
- As of February 25, 2025, MNPR annual cash flow from investing activities is $4.93 million, with the most recent change of +$9.85 million (+200.19%) on December 31, 2023.
- MNPR annual CFI is now at all-time high.
Performance
MNPR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$985.70 K
+$988.10 K+41170.83%
September 30, 2024
Summary
- As of February 25, 2025, MNPR quarterly cash flow from investing activities is $985.70 thousand, with the most recent change of +$988.10 thousand (+41170.83%) on September 30, 2024.
- Over the past year, MNPR quarterly CFI has stayed the same.
- MNPR quarterly CFI is now -66.82% below its all-time high of $2.97 million, reached on December 31, 2023.
Performance
MNPR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$2.97 M
+$998.80 K+50.66%
September 30, 2024
Summary
- As of February 25, 2025, MNPR TTM cash flow from investing activities is $2.97 million, with the most recent change of +$998.80 thousand (+50.66%) on September 30, 2024.
- Over the past year, MNPR TTM CFI has stayed the same.
- MNPR TTM CFI is now -39.72% below its all-time high of $4.93 million, reached on March 31, 2024.
Performance
MNPR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MNPR Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +200.2% | 0.0% | 0.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
MNPR Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +200.2% | -66.8% | +120.0% | -39.7% | +150.3% |
| 5 y | 5-year | at high | +200.2% | -66.8% | +120.0% | -39.7% | +150.3% |
| alltime | all time | at high | +200.2% | -66.8% | +120.0% | -39.7% | +150.3% |
Monopar Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $985.70 K(<-9900.0%) | $2.97 M(+50.7%) |
| Jun 2024 | - | -$2400.00(-99.8%) | $1.97 M(-60.0%) |
| Mar 2024 | - | -$983.30 K(-133.1%) | $4.93 M(+0.0%) |
| Dec 2023 | $4.93 M | $2.97 M(<-9900.0%) | $4.93 M(-266.4%) |
| Sep 2023 | - | -$13.10 K(-100.4%) | -$2.96 M(+0.4%) |
| Jun 2023 | - | $2.95 M(-400.4%) | -$2.95 M(-50.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$983.40 K(-80.0%) | -$5.90 M(+20.0%) |
| Dec 2022 | -$4.92 M(<-9900.0%) | -$4.92 M(<-9900.0%) | -$4.92 M(<-9900.0%) |
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00 | $0.00 |
| Dec 2021 | $0.00 | - | - |
FAQ
- What is Monopar Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Monopar Therapeutics?
- What is Monopar Therapeutics annual CFI year-on-year change?
- What is Monopar Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly CFI year-on-year change?
- What is Monopar Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Monopar Therapeutics?
- What is Monopar Therapeutics TTM CFI year-on-year change?
What is Monopar Therapeutics annual cash flow from investing activities?
The current annual CFI of MNPR is $4.93 M
What is the all time high annual CFI for Monopar Therapeutics?
Monopar Therapeutics all-time high annual cash flow from investing activities is $4.93 M
What is Monopar Therapeutics annual CFI year-on-year change?
Over the past year, MNPR annual cash flow from investing activities has changed by +$9.85 M (+200.19%)
What is Monopar Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of MNPR is $985.70 K
What is the all time high quarterly CFI for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly cash flow from investing activities is $2.97 M
What is Monopar Therapeutics quarterly CFI year-on-year change?
Over the past year, MNPR quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Monopar Therapeutics TTM cash flow from investing activities?
The current TTM CFI of MNPR is $2.97 M
What is the all time high TTM CFI for Monopar Therapeutics?
Monopar Therapeutics all-time high TTM cash flow from investing activities is $4.93 M
What is Monopar Therapeutics TTM CFI year-on-year change?
Over the past year, MNPR TTM cash flow from investing activities has changed by $0.00 (0.00%)